Kennedy Capital Management, Inc. Harvard Bioscience Inc Transaction History

Kennedy Capital Management, Inc.

$4.27 Billion
Q3 2024

A detailed history of Kennedy Capital Management, Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 128,536 shares of HBIO stock, worth $275,067. This represents 0.01% of its overall portfolio holdings.

Number of Shares

128,536

Previous 320,146 59.85%

Holding current value

$275,067

Previous $912,000 62.17%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.64 - $3.54 $505,850 - $678,299	-191,610 Reduced 59.85%	128,536 $345,000
Q2 2024 Aug 14, 2024	SELL	$2.77 - $4.63 $3,814 - $6,375	-1,377 Reduced 0.43%	320,146 $912,000
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $19,143 - $25,667	-4,762 Reduced 1.46%	321,523 $1.36 Million
Q4 2023 Feb 14, 2024	SELL	$4.0 - $5.49 $20,248 - $27,790	-5,062 Reduced 1.53%	326,285 $1.75 Million
Q4 2022 Feb 14, 2023	SELL	$2.12 - $2.86 $108 - $145	-51 Reduced 0.02%	331,347 $917,000
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $1,195 - $2,010	-513 Reduced 0.15%	331,398 $848,000
Q2 2022 Aug 10, 2022	BUY	$3.28 - $6.42 $1.09 Million - $2.13 Million	331,911 New	331,911 $1.2 Million
Q2 2021 Aug 16, 2021	SELL	$5.44 - $8.4 $3.95 Million - $6.1 Million	-725,974 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.91 - $6.99 $987,192 - $1.76 Million	-252,479 Reduced 25.8%	725,974 $3.96 Million
Q4 2020 Feb 12, 2021	SELL	$3.0 - $4.5 $296,697 - $445,045	-98,899 Reduced 9.18%	978,453 $4.2 Million
Q3 2020 Nov 16, 2020	SELL	$2.75 - $4.2 $987,456 - $1.51 Million	-359,075 Reduced 25.0%	1,077,352 $3.24 Million
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.14 $564,935 - $836,744	266,479 Added 22.78%	1,436,427 $4.45 Million
Q1 2020 May 15, 2020	SELL	$1.42 - $3.29 $555,867 - $1.29 Million	-391,456 Reduced 25.07%	1,169,948 $2.59 Million
Q4 2019 Feb 28, 2020	BUY	$2.45 - $3.25 $1.8 Million - $2.38 Million	733,347 Added 88.56%	1,561,404 $4.76 Million
Q4 2019 Feb 14, 2020	SELL	$2.45 - $3.25 $711,712 - $944,108	-290,495 Reduced 25.97%	828,057 $4.76 Million
Q3 2019 Nov 14, 2019	BUY	$1.59 - $3.47 $1.46 Million - $3.19 Million	918,552 Added 459.28%	1,118,552 $3.44 Million
Q2 2019 Aug 14, 2019	BUY	$1.93 - $4.59 $342,378 - $814,256	177,398 Added 784.88%	200,000 $400,000
Q1 2019 May 13, 2019	BUY	$2.77 - $4.38 $62,607 - $98,996	22,602 New	22,602 $97,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Account

Kennedy Capital Management, Inc. Harvard Bioscience Inc Transaction History